Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Iradimed Corp (NQ: IRMD )

48.30 -0.97 (-1.97%)
Streaming Delayed Price Updated: 4:00 PM EDT, Nov 1, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 32,944
Open 49.00
Bid (Size) 44.60 (1)
Ask (Size) 55.00 (1)
Prev. Close 49.27
Today's Range 48.23 - 50.13
52wk Range 39.24 - 53.99
Shares Outstanding 12,673,441
Dividend Yield 2.17%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
IRADIMED CORPORATION Announces Third Quarter of 2024 Financial Results and the Declaration of its Regular Quarterly Cash Dividend of $0.15 Per Share
From iRadimed Corporation
Via GlobeNewswire
IRADIMED CORPORATION to Hold 2024 Third Quarter Financial Results Conference Call on October 31st
From iRadimed Corporation
Via GlobeNewswire

Performance

YTD
+2.14%
+2.14%
1 Month
-3.05%
-3.05%
3 Month
+9.13%
+9.13%
6 Month
+10.81%
+10.81%
1 Year
+13.81%
+13.81%

More News

Read More
IRADIMED CORPORATION to Participate in the 3rd Annual ROTH Healthcare Opportunities Conference
From iRadimed Corporation
Via GlobeNewswire
Earnings Scheduled For February 8, 2024
Via Benzinga
iRadimed's Earnings Outlook
Via Benzinga
Wednesday Is Your Last Chance To Buy iRadimed Before The Dividend Payout
Via Benzinga
Masimo Stock Gets Relative Strength Rating Upgrade
Via Investor's Business Daily
Lytham Partners Announces KOL Panels and Participating Companies for its Fall 2024 Investor Conference
Via Newsfile
IRADIMED CORPORATION To Participate in the Lake St. Annual Best Ideas Growth “Big 8” Investor Conference
From iRadimed Corporation
Via GlobeNewswire
IRADIMED CORPORATION Announces Second Quarter of 2024 Financial Results and the Declaration of its Regular Quarterly Cash Dividend of $0.15 Per Share
From iRadimed Corporation
Via GlobeNewswire
IRADIMED CORPORATION to Hold 2024 Second Quarter Financial Results Conference Call on August 1st
From iRadimed Corporation
Via GlobeNewswire
IRADIMED CORPORATION Announces Uplisting to The Nasdaq Global Market
From iRadimed Corporation
Via GlobeNewswire
IRMD Stock Earnings: iRadimed Beats EPS, Beats Revenue for Q1 2024
Via InvestorPlace
IRADIMED CORPORATION Announces First Quarter of 2024 Financial Results and the Declaration of its Regular Quarterly Cash Dividend of $0.15 Per Share
From iRadimed Corporation
Via GlobeNewswire
IRADIMED CORPORATION to Hold 2024 First Quarter Financial Results Conference Call on May 2nd
From iRadimed Corporation
Via GlobeNewswire
IRADIMED CORPORATION To Participate at the 36th Annual Roth Conference
From iRadimed Corporation
Via GlobeNewswire
IRADIMED CORPORATION Announces Fourth Quarter of 2023 and Full Year of 2023 Financial Results
From iRadimed Corporation
Via GlobeNewswire
IRADIMED CORPORATION to Hold 2023 Fourth Quarter Financial Results Conference Call on February 8th.
From iRadimed Corporation
Via GlobeNewswire
Bruker Stock Rising, Near Buy Point; Gets Rating Upgrade
Via Investor's Business Daily
IRADIMED CORPORATION Reports Unaudited Fourth Quarter and 2023 Revenue
From iRadimed Corporation
Via GlobeNewswire
IRADIMED CORPORATION To Present at the 42nd Annual J.P. Morgan Healthcare Conference
From iRadimed Corporation
Via GlobeNewswire
IRADIMED CORPORATION Announces Establishment of a Quarterly Dividend of $0.15 per share and a Special Cash Dividend of $0.48 per share
From iRadimed Corporation
Via GlobeNewswire
IRADIMED CORPORATION Named a 2024 Most Successful Small-Cap Company in America by Forbes
From iRadimed Corporation
Via GlobeNewswire
IRADIMED CORPORATION Announces Third Quarter 2023 Financial Results
From iRadimed Corporation
Via GlobeNewswire
Earnings Scheduled For November 3, 2023
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.